project id: TCGA-KIRP; case submitter id: TCGA-Q2-A5QZ; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.64; rna integrity number: 7.5; age at index: 61; days to birth: -22531; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1951; age at diagnosis: 22531; ajcc clinical m: MX; ajcc clinical n: NX; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 428.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.821917808219178; pack years smoked: 15.0; years smoked: 15.0; is ffpe: false; composition: Not Reported; days to collection: 48; days to sample procurement: 0; initial weight: 350.0; portion submitter id: TCGA-Q2-A5QZ-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 4.0; percent necrosis: 5.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 65.0; percent tumor nuclei: 85.0;